微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 37.55% | 8.06% | 0.27% | 25/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 37.45% | 6.35% | 0.08% | 25/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 37.42% | 9.92% | 10.77% | 24/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 33.78% | -10.29% | -2.78% | 32/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 34.75% | -11.6% | -1.32% | 32/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 35.21% | -8.31% | 3.43% | 32/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 34.04% | -7.73% | -9.59% | 28/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 37.66% | 8.64% | -4.2% | 32/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 39.31% | 13.23% | 2.36% | 30/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 38.4% | 9.33% | 4.08% | 32/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 36.9% | 4.34% | 6.45% | 30/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 34.66% | 4% | -0.16% | 40/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 34.72% | 7.46% | -1.17% | 36/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 35.13% | 9.8% | -0.66% | 36/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 35.36% | 13.16% | 6.1% | 31/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 33.33% | -11.14% | 3.16% | 41/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 32.31% | -13.44% | 0.98% | 32/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 31.99% | -24.23% | 2.38% | 38/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 31.25% | -20.44% | -16.68% | 25/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 37.51% | 7.66% | 0.5% | 36/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 37.32% | 18.56% | -11.61% | 25/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 42.22% | 32.07% | 7.49% | 19/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 39.28% | 38.34% | 12.74% | 13/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 34.84% | 4.55% | 10.67% | 40/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 31.48% | 1.58% | -1.53% | 26/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 31.97% | 1.69% | 12.6% | 29/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 28.39% | -20.55% | -14.8% | 27/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 33.32% | 6.93% | 7.53% | 38/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 30.99% | -3.13% | -1.43% | 24/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 31.44% | 0.31% | -12.02% | 28/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 35.74% | 15.12% | 14.68% | 21/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 31.16% | 22.03% | -2.6% | 34/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 31.99% | 22.84% | 2.08% | 23/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 31.34% | 28.37% | 0.96% | 25/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 31.04% | 6.38% | 21.56% | 17/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 25.54% | -21.49% | -1.95% | 27/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 26.04% | -21.48% | 6.68% | 17/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 24.41% | -25.37% | -16.33% | 18/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 29.18% | -2.58% | -10.29% | 13/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 32.53% | 16.19% | -1.94% | 21/52 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 33.17% | 24.79% | 1.4% | 13/52 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 32.71% | 20.82% | 9.21% | 13/52 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 29.95% | 2% | 7% | 12/52 | 24.2% | 睿智医药 | 52.68% | 行业排名> |